On Tuesday, 25 March, AmCham EU hosted a discussion on the EU’s forthcoming life sciences strategy and its role in enhancing the sector’s global competitiveness. Ann-Sofie Rönnlund, Member of Cabinet to Commissioner Zaharieva, outlined the Commission’s vision to promote innovation, resilience and patient access. Moderated by Felix Uedelhoven (GE Healthcare), Chair, Healthcare Committee, AmCham EU, the event explored how the EU can create a supportive regulatory and investment environment. Speakers stressed the importance of public-private collaboration and adequate public funding to boost research and innovation, positioning Europe as a global leader in health and ensuring long-term sustainability for patients, healthcare systems and businesses.
How will the EU life science strategy achieve competitiveness?
Related items
:focal())
Healthcare, competitiveness, innovation and simplification
Europe’s life sciences sector sits at the heart of the EU’s competitiveness agenda. It supports advanced manufacturing and helps bring new treatments and technologies to patients. Yet companies deciding where to invest need a regulatory environment that is predictable and open to global cooperation.
The European Commission’s work on the Biotech Act and the targeted revision of the Medical Devices and In Vitro Diagnostics Regulations (MDR/IVDR) offers an opportunity to improve that environment. Both files can help make Europe a stronger location for life sciences investment.
The EU should use this moment to build a framework that keeps pace with scientific progress. That means faster and clearer procedures. It also means better use of data and intellectual property rules that recognise the realities of global supply chains.
:focal())
Strengthening EU competitiveness through an adaptive MDR/IVDR framework
A global approach to strengthening Europe’s biotechnology ecosystem
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.